HI-Blog

October 3, 2017

Retail Pays in Million Dollar Ways

Very quick note:  for the first time in over three years of profiting off of the sale of Schedule 1 drugs, Washington State collected, on average, over ONE MILLION DOLLARS of excise tax revenue per day during the month of September. I’d do a graph, but that would be overkill. Average Excise Tax per day in Sept — $1,018,411 Statewide, that is just under $1.2 Million per day once state sales tax is rolled in. From a revenue perspective, retail is now moving (before taxes) over $2,750,000 of State-legal Cannabis […]
September 14, 2017

Retail Performance Assessment

This is to inform my readers that I am going to be shifting the focus of HI-Blog to issues related to Retail Performance in Washington’s State-legal Cannabis market. While this will shift the emphasis in HI-Blog away from the “labs” and from the failed integration of Medical Cannabis into the state’s regulated system, I expect to continue writing on those topics in other industry publications. In no particular order, the topics I expect to cover in HI-Blog’s Retail Performance series will include assessments of: wholesale purchase pricing by retail stores […]
August 22, 2017

The Hempfest Bump – Retail Sales Increase

During the 3 days of Hempfest weekend, Statewide retail sales (not counting taxes) at the Retail Access Points were: Friday $3,495,000 Saturday $2,928,000 Sunday $2,258,000 These represent (relative to the same day the prior week), increases of 4.8%, 7.1% and 1.2%, respectively. It is not every week one sees increases like this. That Hempfest likely drove that bump is really neat. Given what I saw and learned over the weekend, Hempfest is more relevant than ever. Long live Hempfest … and when are we going to see more of those […]
August 14, 2017

Risk Assessment Methods

Over the past 10 days, I have posted on HI-Blog relating to the recent suspension of the certification of PEAK Analytics to test State-legal Cannabis in Washington. Those posts and subsequent communications have alerted the WSLCB, the public, and industry participants to the exposure risk stemming from the continued availability of PEAK-tested product in Retail Access Points. They also allude to the non-zero risk of morbidity and mortality associated with such exposure. Some of the comments I’ve seen relating to my work regarding PEAK’s inadequacy in testing for “Total Coliforms” […]